| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$52 |
Change of Director's Interest Notice
|
2 Jul 2025 8:24AM |
$0.063 |
$0.120 |
risen by
90.48%
|
|
| Babylon Pump & Power Limited (BPP) ORDINARY FULLY PAID |
Industrials |
$10 |
Change of Director's Interest Notice
|
2 Jul 2025 8:23AM |
$0.006 |
$0.078 |
risen by
1,191.67%
|
|
| Babylon Pump & Power Limited (BPP) ORDINARY FULLY PAID |
Industrials |
$10 |
Cleansing Notice
|
2 Jul 2025 8:23AM |
$0.006 |
$0.078 |
risen by
1,191.67%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$973 |
Update - Notification of buy-back - KAR
|
2 Jul 2025 8:23AM |
$1.910 |
$1.370 |
fallen by
28.27%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,736 |
Update - Notification of buy-back - DNL
|
2 Jul 2025 8:23AM |
$2.710 |
$3.840 |
risen by
41.70%
|
|
| Latitude 66 Limited (LAT) ORDINARY FULLY PAID |
Materials |
$15 |
Sale of Non-Core Interest in Greater Duchess Copper Gold JV
|
2 Jul 2025 8:23AM |
$0.023 |
$0.100 |
risen by
334.78%
|
|
LAT - Price-sensitive ASX Announcement
Full Release
Key Points
- LAT entered into a Sale and Purchase Agreement to divest its 80% interest in the Greater Duchess Copper Gold JV Project.
- The divestment is to Copper Search Limited for a cash consideration of A$400,000 and a royalty over future production.
- The Greater Duchess Project is located in Queensland and is considered non-core to LAT’s strategic focus.
- The transaction allows LAT to concentrate on its flagship Kuusamo Schist Belt projects in Finland.
- LAT retains exposure to any upside via a royalty on future production from the Greater Duchess Project.
- The divestment aligns with LAT’s strategy to rationalise its portfolio and focus on core assets.
- Completion of the sale is subject to standard conditions including regulatory approvals.
- The announcement reiterates LAT’s commitment to advancing its Finnish gold projects while unlocking value from non-core assets.
- Copper Search Limited will assume all obligations related to the Greater Duchess Project post-completion.
- The transaction is expected to strengthen LAT’s balance sheet and provide additional working capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$104 |
Greenewood gold - Maiden drill program to commence
|
2 Jul 2025 8:23AM |
$0.040 |
$0.080 |
risen by
100%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota Limited is launching a maiden drill program at the Greenewood gold discovery.
- Greenewood is located on MEU’s tenement in the Gawler Craton, South Australia.
- The discovery lies about 5km north of the Aurora Tank gold project.
- The drill program will consist of approximately 40 holes targeting high-priority prospects.
- Targets were identified using auger drilling and geochemical analysis.
- Early exploration results at Greenewood have been promising.
- This initiative is part of Marmota’s broader gold exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sandfire Resources Limited (SFR) ORDINARY FULLY PAID |
Materials |
$9,185 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:23AM |
$11.120 |
$19.670 |
risen by
76.89%
|
|
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
Statement of CDIs on issue - 5EA
|
2 Jul 2025 8:23AM |
$0.500 |
$0.250 |
fallen by
50%
|
|
| James Hardie Industries Plc (JHX) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$20,323 |
Appointment of New Non-Executive Directors & ATO Ruling
|
2 Jul 2025 8:23AM |
$40.770 |
$35.020 |
fallen by
14.10%
|
|
| Deterra Royalties Limited (DRR) ORDINARY FULLY PAID |
Materials |
$2,388 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:22AM |
$3.760 |
$4.510 |
risen by
19.95%
|
|
| Gumtree Australia Markets Limited (GUM) ORDINARY FULLY PAID |
Communication Services |
$29 |
Change in substantial holding
|
2 Jul 2025 8:22AM |
$0.095 |
$0.090 |
fallen by
5.26%
|
|
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$3,442 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:22AM |
$2.290 |
$3.010 |
risen by
31.44%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$58,765 |
Notice of Proposed Sale of Securities
|
2 Jul 2025 8:22AM |
$102.330 |
$105.250 |
risen by
2.85%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$21,132 |
Form 8-K, Items 8.01 and 9.01
|
2 Jul 2025 8:22AM |
$45.030 |
$80.080 |
risen by
77.84%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,919 |
Net Tangible Asset Backing
|
2 Jul 2025 8:21AM |
$2.870 |
$4.600 |
risen by
60.28%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$477 |
Change of Director's Interest Notice - James Calaway
|
2 Jul 2025 8:21AM |
$0.098 |
$0.155 |
risen by
58.16%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$477 |
Change of Director's Interest Notice - Bernard Rowe
|
2 Jul 2025 8:21AM |
$0.098 |
$0.155 |
risen by
58.16%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$522 |
Updated Pre-Feasibility Study Presentation
|
2 Jul 2025 8:21AM |
$0.535 |
$0.530 |
fallen by
0.93%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$477 |
Notification of cessation of securities - INR
|
2 Jul 2025 8:21AM |
$0.098 |
$0.155 |
risen by
58.16%
|
|
| Vault Minerals Limited (VAU) ORDINARY FULLY PAID |
Materials |
$4,759 |
Ceasing to be a substantial holder
|
2 Jul 2025 8:21AM |
$0.420 |
$4.600 |
risen by
995.24%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$514 |
Notification of cessation of securities - CUV
|
2 Jul 2025 8:21AM |
$10.120 |
$10.200 |
risen by
0.79%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$477 |
Application for quotation of securities - INR
|
2 Jul 2025 8:21AM |
$0.098 |
$0.155 |
risen by
58.16%
|
|
| Pancontinental Energy NL (PCL) ORDINARY FULLY PAID |
Energy |
$75 |
PEL 87 Technical Update
|
2 Jul 2025 8:21AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
PCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Technical update on PEL 87 offshore Namibia released by Pancontinental Energy NL.
- The Saturn Turbidite Complex within PEL 87 is identified as a key prospective area.
- Seismic interpretation indicates significant reservoir potential, similar to neighboring discoveries.
- Recent regional drilling successes have increased interest and de-risked the area.
- Pancontinental is conducting further technical studies and seeking farmout partners.
- PEL 87 is positioned within a proven oil fairway, enhancing exploration confidence.
- The company is preparing for a potential drilling campaign pending successful farmout and technical results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$142 |
Key Developments in Pivotal Trial & Innovation Study
|
2 Jul 2025 8:21AM |
$1.745 |
$1.525 |
fallen by
12.61%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- EMvision Medical Devices Limited (EMV) provided a comprehensive update on key developments related to its pivotal clinical trial and innovation study.
- The pivotal trial aims to validate the efficacy and safety of EMVision's portable brain scanner for stroke diagnosis and monitoring.
- The trial has commenced with recruitment, and the company has emphasized the importance of achieving sufficient patient enrolment to meet regulatory and clinical endpoints.
- Initial feedback from trial sites has been positive, with clinicians noting the potential impact of the EMVision device on acute stroke care pathways.
- The company highlighted ongoing collaboration with major Australian hospitals and international clinical partners.
- Data from the pivotal trial will inform regulatory submissions and commercial strategy for market entry.
- EMVision is also running an innovation study focused on expanding the device’s applications beyond stroke, including traumatic brain injury and neurological monitoring.
- The innovation study involves advanced imaging algorithms and integration with other clinical data sources to enhance diagnostic performance.
- EMVision reported progress on device manufacturing scale-up and quality management processes to prepare for commercial deployment.
- The company’s management reiterated commitment to transparency with stakeholders and regular communication as the pivotal trial and innovation study progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.